Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Invokana (canagliflozin), Vokanamet (canagliflozin, metformin) - Important Safety Information from Janssen-Cilag Limited as approved by the HPRA
Notice type:
3rd Party Publications
Date:
04/05/2016
Problem Or Issue:
Important Safety Information communication from Janssen-Cilag Limited on risk of Lower Limb Amputation (Primarily of the Toe) associated with Canagliflozin-Containing Medicines Invokana (canagliflozin), Vokanamet (canagliflozin, metformin).
Important Safety Information - Invokana (canagliflozin), Vokanamet (canagliflozin, metformin)
« Back
Date Printed: 25/04/2024